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Robotic surgery: will it be evidence-based or just “toys for boys”?
Guy J Maddern
Surgeons and government must work together to evaluate new surgical technologies
obot-assisted surgery has been evolving over the past 
decade, from simple adjustable arms to support cameras in 
laparoscopic surgery, through to the more sophisticated 
four-armed machines now being installed in a number of hospitals 
in Australia.1 The name “robot” is somewhat misleading, as these 
devices do not perform autonomous tasks, but are under the direct 
control of a surgeon who usually works from a remote console to 
insert robot-controlled instruments into a patient. This technology 
has certainly made a number of surgical procedures, such as total 
prostatectomy and cardiac anastomosis (coronary artery bypass 
grafting), somewhat easier to perform; however, the true benefit of 
these interventions is yet to be clearly demonstrated.2
Over the past 150 years, surgery has been driven by technolog-
ical advances. The introduction of anaesthesia; the development 
of imaging, from x-rays through to ultrasound, computed tomo-
graphy scanning, and magnetic resonance imaging; and the 
availability in the operating theatre of heart/lung machines, 
stereotactic-guided imaging systems, and an array of extraord-
inary prosthetic inserts for the heart, joints and the vascular 
system have all meant that surgeons are constantly being chal-
lenged by new technologies. The benefits gained from the 
introduction of laparoscopic surgery into general surgical pro-
cedures over the past 15 years have also been possible only 
through the advances of technology. With these developments 
has been the need to adapt practice, as new technologies are 
demonstrated to be of value to patients. Not all new technologies 
have survived the test of time, however, and some fail on long-
term review to deliver on their early promise.3,4
While hundreds of robotic systems have been sold worldwide, 
there are presently four commissioned robots in practice in 
Australia. One is located in a public hospital; the other three are in 
private hospitals. This has caused some concern within segments 
of the surgical community, as the motives for installing these 
robotic machines appear to be more commercial and marketing-
oriented than based on well established science and surgical 
benefit. However, since more than half of the surgical procedures 
in our health system are performed in the private sector, it is hardly 
surprising that aggressive marketing and commercial interests 
should be factors in the availability of robotic surgery. Is this in the 
best interests of the Australian community, the patients treated and 
the associated cost for the health care system? The purchase price 
of robotic machines varies but is in the range of $1.5–$2 million.5,6
The costs of disposable items required for a procedure are also 
substantial, adding a large premium to each surgery performed. If 
clear and measurable benefits result from robotic surgery, then 
these costs may be easy to defend and should be supported. But a 
fundamental issue is why, if the benefits are so tangible, does 
robotic surgery occur predominantly in private facilities? It may be 
that the funding is only available within the private sector, or it 
may be due to a lack of current clear evidence that there is true 
benefit associated with this technology.7 Indeed, if all the robots 
were removed from surgical practice tomorrow, the impact on the 
health care system would not be significant; the overall cost may, 
in fact, drop.
The introduction of robotic surgery has many potential advan-
tages. It makes difficult and previously inaccessible body areas 
easier for surgeons to access and may lead to decreased morbidity 
for patients.7 There are exciting prospects for using robotic systems 
remotely — where the surgeon operates on a patient who is 
heading to Mars, remotely located in Antarctica, or close to the 
frontline of a battlefield — none of which are beyond the realms of 
possibility with the level of technology currently available.8,9
Furthermore, the possibility for surgeons to perform simulated 
surgery based on a patient’s imaging information and to prepare a 
range of operative strategies for difficult and complex cases will be 
greatly facilitated by the availability of robotic systems that are 
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interfaced with computed tomography and magnetic resonance 
imaging scans and ultrasound information, all brought together in 
a virtual surgical environment.7,8
We need health professionals who are excited by new develop-
ments and new opportunities. Without them we would still be 
practising surgery as it had been done for hundreds of years. It is 
unfortunate that our health care system spends much of its energy 
trying to hold back innovation and development on the basis that 
funding is unavailable or evidence of benefit is yet to appear. 
Evidence demonstrating the value of new surgical interventions 
takes time; its acquisition needs to be properly funded and 
supported and it needs to be honestly collected and evaluated. 
Since the Australian Government is the major funder of health care 
in Australia, and even in the private sector contributes 75% of the 
scheduled fee for surgical procedures, it has a vital interest in 
setting up systems where all new surgical technologies (the robot 
being no exception) are monitored, evaluated and reported on. 
Most such systems are currently somewhat ad hoc. One exception 
is the Australian Safety and Efficacy Register of New Interventional 
Procedures – Surgical (ASERNIP-S), an organisation run by the 
Royal Australasian College of Surgeons with funding from the 
Australian Government to evaluate new surgical technologies 
(http://www.surgeons.org/asernip-s/).
If we are to have cost-effective surgical care that is innovative 
and relevant, we need the Australian Government to recognise that 
for all important new technologies, trials are established, data 
collected and the information fed back to hospitals, doctors and 
patients. There is clearly a cost involved in such activities, but 
introducing a poor technology without clear patient outcomes in 
the long term is a much more expensive activity. The challenge for 
surgeons and government is to work together as a team, with the 
surgeons agreeing to appropriate protocols and careful evaluation, 
and the Australian Government recognising that this innovation 
needs to be funded from the public purse.
“Toys for boys” implies a somewhat frivolous approach to new 
technologies. This is probably not the case. Rather, surgeons — 
male or female — are excited by new technologies and the 
possibilities they offer for the care of their patients. Robotic surgery 
will become commonplace over the next 10 years. These machines 
will not replace surgeons, but will provide added precision and 
enable surgeons to work on difficult cases, regardless of location. 
The robots will become cheaper, smaller and easier to use. There 
will be tactile feedback mechanisms and instrumentation inte-
grated into the robot’s arms to enable imaging and sampling to 
occur at the same time as the procedure is being performed. Just as 
artificial hips, heart valves and heart/lung machines seemed far-
fetched 50 years ago, so too we will look back on this first decade 
of robotic surgery as the beginning of a major change in the way in 
which surgery is evaluated and delivered, and care is managed for 
patients.
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